Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals

J Endocrinol Invest. 2024 Sep;47(9):2249-2260. doi: 10.1007/s40618-024-02323-4. Epub 2024 Mar 9.

Abstract

Background: The organ-specific effects of gender-affirming sex hormone treatment (GAHT) in transgender women (TW) and transgender men (TM) are insufficiently explored. This study investigated the effects of GAHT on adipose tissue function.

Methods: In a single-center interventional prospective study, 32 adults undergoing GAHT, 15 TW and 17 TM, were examined with anthropometry and abdominal subcutaneous adipose tissue biopsies obtained before initiation of treatment, 1 month after endogenous sex hormone inhibition and three and 11 months after initiated GAHT. Fat cell size, basal/stimulated lipolysis and cytokine secretion in adipose tissue were analyzed.

Results: TW displayed an increase in complement component 3a and retinol-binding protein 4 (RBP4) secretion after sex hormone inhibition, which returned to baseline following estradiol treatment. No changes in lipolysis were seen in TW. TM showed downregulation of RBP4 after treatment, but no changes in basal lipolysis. In TM, the estrogen suppression led to higher noradrenaline stimulated (NA) lipolysis that was normalized following testosterone treatment. At 11 months, the ratio of NA/basal lipolysis was lower compared to baseline. There were no significant changes in fat cell size in either TW or TM.

Conclusion: In TW, gonadal hormone suppression results in transient changes in cytokines and in TM there are some changes in NA-stimulated lipolysis following testosterone treatment. However, despite the known metabolic effects of sex hormones, the overall effects of GAHT on adipose tissue function are small and likely have limited clinical relevance, but larger studies with longer follow-up are needed to confirm these findings.

Trial registration: ClinicalTrials.gov Identifier: NCT02518009, Retrospectively registered 7 August 2015.

Keywords: Adipose tissue; Lipolysis; Transgender; Transmen; Transwomen.

Publication types

  • Observational Study

MeSH terms

  • Adipokines* / analysis
  • Adipokines* / metabolism
  • Adult
  • Female
  • Follow-Up Studies
  • Gonadal Steroid Hormones / antagonists & inhibitors
  • Gonadal Steroid Hormones / metabolism
  • Humans
  • Lipolysis* / drug effects
  • Male
  • Prospective Studies
  • Sex Reassignment Procedures / methods
  • Testosterone / administration & dosage
  • Transgender Persons*
  • Young Adult

Substances

  • Adipokines
  • Gonadal Steroid Hormones
  • Testosterone

Associated data

  • ClinicalTrials.gov/NCT02518009